C. Lhommé
Institut Gustave Roussy · 423 works · 10,359 citations · h-index 56
Top works
- Malignant effusions and immunogenic tumour-derived exosomes
- Cutaneous side-effects of kinase inhibitors and blocking antibodies
- Lymph Node Involvement in Epithelial Ovarian Cancer: Analysis of 276 Pelvic and Paraaortic Lymphadenectomies and Surgical Implications
- Detection of Minimal Levels of Serum Anti-Mullerian Hormone during Follow-Up of Patients with Ovarian Granulosa Cell Tumor by Means of a Highly Sensitive Enzyme-Linked Immunosorbent Assay
- The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients
- Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms.
- Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial
- Prognostic value of initial surgical procedure for patients with uterine sarcoma: analysis of 123 patients.
- Combined radiotherapy and surgery: local control and complications in early carcinoma of the uterine cervix — the Villejuif experience, 1975–1984
- Antimüllerian hormone as a serum marker of granulosa cell tumors of the ovary: Comparative study with serum α-inhibin and estradiol
- Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers.
- Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging.
- Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer
- Prognostic factors for patients with advanced stage serous borderline tumours of the ovary
- Kidney Diseases Associated With Anti-Vascular Endothelial Growth Factor (VEGF)
- Radiotherapy after ovarian transposition: Ovarian function and fertility preservation
- Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Française d'Oncologie Gynécologique)
- Extensive cytoreductive surgery in advanced ovarian carcinoma.
- Impact of surgical staging in patients with macroscopic “stage I” ovarian borderline tumours: analysis of a continuous series of 101 cases
- Results of interval debulking surgery in advanced stage ovarian cancer: an exposed–non-exposed study